Advances in allergic skin disease: omalizumab is a promising therapy for urticaria and angioedema

J Allergy Clin Immunol. 2009 Jan;123(1):273-4. doi: 10.1016/j.jaci.2008.07.033. Epub 2008 Sep 5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anaphylaxis / epidemiology
  • Anaphylaxis / etiology
  • Anaphylaxis / immunology*
  • Animals
  • Clinical Trials as Topic
  • Drug Hypersensitivity / immunology*
  • Food Hypersensitivity / epidemiology
  • Food Hypersensitivity / immunology*
  • Food Hypersensitivity / prevention & control
  • Humans
  • Insect Bites and Stings / immunology*
  • Skin Diseases / etiology
  • Skin Diseases / immunology*
  • Skin Diseases / therapy